Brain organoids have emerged as powerful tools in neuroscience research, providing unique opportunities to study brain development, disease mechanisms, and potential therapeutic interventions. The utility of brain organoids in neuroscience research lies in their ability to replicate key aspects of human brain development, structure, function, and pathology, offering insights that are difficult to obtain from traditional two-dimensional (2D) cell cultures or from animal models.

With advances in bioengineering and differentiation protocols, brain organoids increasingly mimic the architecture and function of the developing human brain. This allows researchers to study the complex interactions between different cell types and the effects of genetic mutations on brain development.

Brain organoids are invaluable for modeling human neurodevelopmental disorders, such as autism and schizophrenia as well as neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s (PD). These models also enhance drug discovery and toxicity testing by providing a more relevant platform for assessing the efficacy and safety of new therapies.

Like other types of organoids, brain organoids hold immense promise in the field of personalized medicine, enabling researchers to create patient-specific models in order to gain crucial insights into disease mechanisms and develop targeted treatments.

Types of brain organoids

Brain organoids can be broadly classified into unguided (self-organizing) and guided (region-specific) types. Unguided cerebral organoids develop spontaneously, forming diverse brain regions. In contrast, guided organoids are engineered using specific growth factors to mimic particular brain regions. For example, cerebral organoids model cortical development, midbrain organoids generate dopaminergic neurons, hindbrain/cerebellar organoids replicate cerebellar structures, and hypothalamic organoids simulate neuroendocrine interactions. These models provide precise tools for studying brain development and disease mechanisms.

Unguided Cerebral organoids

Cerebral organoids are the most common type of brain organoid in use. They typically contain multiple brain regions, primarily representing structures from the forebrain, midbrain and hindbrain which lack clearly defined boundaries. They are generated in an “unguided” approach, meaning they are self-patterned via intrinsic cues.

Although these organoids exhibit general brain-like properties, their organization, albeit complex, is less precise. Their complexity and heterogeneity do make them valuable models for studying broad aspects of brain development, as they exhibit gene expression patterns akin to those of the developing fetal brain. However, this same complexity can also lead to high variability between organoids, an important consideration when designing experiments.

Region-specific brain organoids

Region-specific organoids are 3D cell cultures designed to replicate specific areas of the brain, such as the hippocampus, thalamus, and cortex. These models allow detailed studies of specialized brain functions including memory formation, motor control and sensory processing. They are generated using a “guided” approach, in which extrinsic signaling factors, such as Wnt, FGF, and retinoic acid are used to induce differentiation of pluripotent stem cells towards specific cell fates. By carefully manipulating these extrinsic factors, researchers can guide developing brain organoids to mimic specific brain regions. Thus, region-specific organoids allow for more targeted studies of region-specific brain disorders such as AD and PD.

Development and generation of brain organoids

Brain organoids are generated from pluripotent stem cells, primarily induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs):

Induced pluripotent stem cells (iPSCs): These are somatic cells that have been reprogrammed to a pluripotent state, allowing them to differentiate into any cell type, including neurons and glia. iPSCs can be derived from various adult tissues, such as skin or blood, using specific factors (such as Oct4, Sox2, Klf4, and c-Myc) that induce pluripotency. Once established, iPSCs can be cultured and differentiated into neural progenitor cells, which serve as the foundation for generating brain organoids.

Embryonic stem cells (ESCs): These are cells derived from the inner cell mass of blastocysts and are naturally pluripotent, capable of differentiating into any cell type in the body. ESCs are isolated from early-stage embryos and cultured under specific conditions to maintain their pluripotency. Similar to iPSCs, ESCs can be directed to differentiate into neural progenitor cells through specific signaling pathways and growth factors.

The process of creating brain organoids involves several key stages:

• Initial culture: hPSCs are cultured in specific conditions to maintain their pluripotency.
• Embryoid body formation: The stem cells are aggregated to form three-dimensional clusters called embryoid bodies, containing endoderm, mesoderm, and ectoderm layers.
• Neural induction: The embryoid bodies are exposed to factors that promote neuroectodermal differentiation.
• 3D culture: The neuroectodermal tissues are embedded in a matrix (often Matrigel) to support three-dimensional growth.
• Differentiation and self-organization: Under appropriate conditions, cells differentiate into various neural cell types and self-organize into structures resembling aspects of brain architecture.
• Maturation: The developing organoids are cultured in specialized media to promote further differentiation and organization. This stage can last several months.

As mentioned previously, there are two main approaches for brain organoid formation unguided protocols and guided protocols:

Growth and maturation stages in brain organoids

Brain organoids progress through various stages of growth and maturation, mirroring aspects of human brain development. In the early stage (around 1 month), neurons begin to appear, and markers for astrocytes and microglia start to increase. By mid-stage (1–3 months), the organoids show more diverse neural cell types, including glutamatergic and GABAergic neurons, and functional properties such as spontaneous calcium transients emerge.

The late stage (3+ months) is characterized by the gradual appearance of oligodendrocytes and more complex neural networks. Electrophysiological maturation progresses over time, with synchronized burst firing activities and both action and spontaneous inhibitory/excitatory postsynaptic potentials emerging from about 2 months.

More advanced functional properties, such as periodic oscillatory activity and synaptic plasticity, develop around 5–6 months. Notably, some studies have observed that between 250–300 days in culture brain organoids can reach postnatal-like stages, which parallels in vivo development.

Cellular diversity in brain organoids

Brain organoids demonstrate remarkable cellular diversity, recapitulating many aspects of the human brain's complex cellular composition. Studies have shown that these 3D cultures can generate a broad range of cell types that closely resemble those found in the human brain, for example:

• Excitatory and inhibitory neurons: Different subtypes of excitatory and inhibitory neurons are formed, including excitatory neurons with specific cortical layer identities, cortical projection neurons, and interneurons.
• Progenitor cells: Intermediate progenitor cells and radial glial cells
• Glial cells: Astrocytes and oligodendrocyte precursor cells
• Retinal cells: Bipolar cells, rods, and retinal ganglion cells

While brain organoids show impressive cellular diversity, it's important to note that they still have limitations. Most notably, they typically lack vascular cells, immune cells, and other non-neural cells found in the in vivo brain. Ongoing research aims to address these limitations and further improve the fidelity of brain organoids as models of human brain development and function.

Applications of brain organoids in research

Brain organoids are an exciting advancement in biomedical research, offering a range of applications that drive our understanding of the brain and its disorders. Here are some key areas where brain organoids are used:

Neurodevelopmental research

Brain organoids are proving to be invaluable tools for understanding human brain development. They can mimic the dynamic spatiotemporal process of early brain development, allowing researchers to observe and analyze key developmental stages. Models have been used to study neurogenesis, gliogenesis, synaptogenesis, and the formation of complex cytoarchitecture. By comparing brain organoids derived from human and non-human primate stem cells, scientists can also investigate human-specific aspects of brain evolution and development.

Disease modeling

While brain organoids are very useful in modeling a wide range of brain diseases, particularly those initiated by a genetic cause or developmental origin, it is important to note that they have limitations. These models may not fully replicate the complex environment of the human brain, and their use in evaluating potential therapies should be considered in conjunction with other experimental models.

Neurodevelopmental disorders

Organoids have been used to model neurodevelopmental disorders such as autism spectrum disorders and schizophrenia. Using these models, researchers can identify cellular and molecular defects that may cause these disorders and test potential therapies. Additionally, by generating organoids from patient-derived induced pluripotent stem cells (iPSCs), researchers can study the cellular and molecular mechanisms underlying these conditions in a physiologically relevant context.

Neurodegenerative diseases

Brain organoids have emerged as powerful tools for studying neurodegenerative diseases, offering insights into complex pathological processes that are difficult to model in traditional 2D cultures or animal models. Recent advancements have shown promising results in modeling conditions such as AD, PD, and amyotrophic lateral sclerosis (ALS).

In the case of AD, brain organoids generated from patients with genetic variants have successfully recapitulated key molecular hallmarks, including Aβ aggregation and tau hyperphosphorylation. These advancements in brain organoid technology are providing unprecedented opportunities to study the molecular mechanisms underlying neurodegenerative diseases and to test potential therapeutic strategies in a human-specific context.

Drug discovery and toxicity testing

Brain organoids are becoming essential in drug discovery and toxicity testing. They provide a more accurate model for studying the safety and efficacy of new medications because they more closely resemble the behavior of human brain cells than standard animal models or 2D cell cultures. Researchers can use organoids to evaluate medications for toxicity, side effects, and efficacy before they enter clinical trials, leading to more efficient drug development processes and reducing reliance on animal models.

Personalized medicine and patient-specific organoids

One of the most promising applications of brain organoids is in the field of personalized medicine. By creating organoids from a patient’s cells, scientists can examine how individuals respond to treatments and create personalized therapeutic plans. This approach is particularly valuable for rare genetic disorders or complex conditions where patient-to-patient variability is high.

Advanced techniques and innovations in brain organoid research

Brain organoid research has seen significant advancements and innovations, enabling more accurate modeling of human brain development and function. These innovations are driven by cutting-edge techniques in cell culture, genetic engineering, and multi-disciplinary integration.

Vascularized brain organoids

One of the major limitations of traditional brain organoids has been the lack of a functional vascular system, which is crucial for nutrient and oxygen delivery. Vascularized brain organoids are brain organoids enhanced with vascular-like structures that better replicate the human brain neurovascular structure, such as a blood-brain barrier. The presence of these structures significantly enhances the functional maturation of organoids.

Vascularized brain organoids can be created via co-culture techniques in which endothelial cells or iPSC-derived endothelial cells are cultured along with brain organoids, or by co-culturing vessel organoids with brain organoids. Additionally, researchers have engineered human embryonic stem cells to express ETS variant 2 (ETV2), leading to the formation of complex vascular-like networks within brain organoids.

These vascularized organoids have several advantages: they integrate more effectively into host tissues, better mimic neurovascular environments with features such as the blood-brain barrier, and serve as valuable models for studying neurovascular interactions in human biology, which could lead to breakthroughs in understanding brain disorders and developing targeted treatments.

Assembloids and fused organoids

Assembloids and fused organoids represent the next generation of brain organoids, combining multiple brain regions or cell lineages to create more complex 3D cultures. Fused organoids are 3D cellular structures created by combining two or more pre-patterned organoids representing different brain regions or tissues. Assembloids are formed by integrating multiple organoids or combining organoids with additional cell types or primary tissue explants.

In general, assembloids achieve a higher level of structural and functional complexity than fused organoids, better mimicking the intricate interactions and emergent properties of the human brain. Both enable researchers to study inter-tissue and inter-lineage cellular interactions, providing insights into complex developmental processes and disease mechanisms, and emergent tissue properties that are not captured by traditional organoid models.

Integration of organoids and artificial intelligence

Organoid intelligence (OI) is an emerging interdisciplinary field that combines organoid technology and artificial intelligence (AI) to develop biologically based computing systems, and to model cognition and study brain function and dysfunction. OI involves interfacing brain organoids with AI and advanced recording technologies to harness the computational capabilities of biological neural networks, with the goal of creating more efficient and powerful computing systems while using less energy than traditional silicon-based computers.

This fusion has the potential to advance neuroscience, biomedical research, drug development, brain-machine interfaces and biocomputing. OI is still an emerging field with significant potential, but many of its proposed applications are still in the research and development stage.

Scientific limitations of brain organoids

Although brain organoids have emerged as powerful tools for studying human brain development and neurological disorders, they are still far from replicating the complexity of the human brain. Several scientific limitations currently hinder their full potential as research models:

Variability and reproducibility issues

One of the most significant challenges in brain organoid research is the lack of reproducibility and high variability between organoids. This issue stems from several factors:

• Stochastic nature of stem cell differentiation and self-assembly, leading to heterogeneity in organoid composition and structure.
• Variability in commercially available media, serum batches, and extracellular matrices.
• Differences in cell sources, isolation methods, and reprogramming techniques for induced pluripotent stem cells (iPSCs).
• Multiple rosettes within each organoid acting as independent organizing centers, resulting in unpredictable organization.

Structural and functional limitations

Brain organoids face several structural and functional limitations that constrain their utility as comprehensive models of the human brain. These include the lack of complete brain cytoarchitecture and the absence of certain cell types, such as microglia and vascular tissue, which are crucial for normal brain function. The absence of a blood-brain barrier and proper vascularization limits nutrient and oxygen supply, particularly to the organoid’s core, potentially leading to necrosis in long-term cultures. This issue also hinders the ability to maintain organoids for extended periods, making it challenging to model later stages of brain development and aging processes.

Brain organoids struggle to replicate the complexity of neural circuits and connections found in the human brain, limiting their capacity to model intricate brain functions and network dynamics. These limitations collectively influence the organoids’ ability to fully recapitulate human brain development and function, necessitating ongoing research to overcome these challenges.

To overcome these limitations, researchers are working on developing more advanced organoid models, including assembloids and fused organoids that combine multiple brain regions. Additionally, efforts are being made to improve vascularization, incorporate immune cells, and extend culture durations.

Ethical considerations in brain organoid research

Brain organoid research presents a range of ethical challenges that must be addressed to ensure responsible scientific progress. These issues arise from the unique characteristics of brain organoids, including their potential for consciousness, the complexities of informed consent, and the implications of their use in research and therapy. Below are a few key ethical considerations associated with brain organoids:

• Moral status and consciousness: One of the most debated ethical issues is the potential for brain organoids to develop consciousness or cognitive functions. As organoids become more complex and exhibit brain-like properties, questions arise about their moral status and whether they should be afforded certain protection similar to those given to human and animal research participants. This consideration necessitates ongoing discussions about when, if ever, organoids might attain sentience and what ethical obligations researchers would have in such cases.
• Informed consent: The procurement of human biomaterials for generating brain organoids raises significant concerns regarding informed consent. When using induced pluripotent stem cells (iPSCs) derived from adult donors, obtaining consent is relatively straightforward. However, challenges arise when dealing with donors who may lack the capacity to give informed consent, such as children or individuals with cognitive impairments. In these cases, legal guardians must be fully engaged in the consent process.
• Research oversight and regulation: As brain organoid research progresses rapidly, there is a pressing need for robust oversight frameworks to ensure ethical compliance. Current regulatory structures may not adequately address the unique challenges posed by brain organoids, particularly regarding their use in preclinical testing and commercialization. Establishing clear guidelines for oversight can help balance innovation with ethical responsibility.
• Animal research and chimeras: The integration of human brain organoids into animal models raises ethical concerns related to animal welfare and the implications of creating human-animal chimeras. When human cells are introduced into non-human animals, it is important to consider how these interventions might affect animal behavior and welfare. Ethical review processes must ensure that such experiments adhere to established animal welfare principles while also addressing the specific complexities introduced by human-to-animal chimerism.
• Commercialization and intellectual property: The commercialization of brain organoids brings additional ethical challenges related to ownership, patenting, and equitable access to advancements derived from this research. As organoids are developed for therapeutic applications, questions arise about who owns the intellectual property associated with them and how benefits will be distributed across society. Ensuring fair access to organoid technology while navigating commercial interests is an important concern.

As the field progresses, it is crucial for scientists, ethicists, and policymakers to collaborate in addressing these challenges and establishing guidelines for responsible brain organoid research. By doing so, we can harness the full potential of these powerful tools to advance our understanding of human brain development and neurological disorders.

FAQs

What are the main differences between unguided and guided brain organoid protocols?

Unguided brain organoid procedures provide stem cells with the freedom to self-organize into organoid structures without any guidance, producing properties that are broadly similar to those of the brain but lack clear regional order.

Guided protocols, on the other hand, use specialized growth factors and signaling molecules to control the development of specific brain regions, such as the hindbrain or forebrain. By producing organoids with distinct regional structures, this method more closely resembles the development of the human brain. It makes it possible to investigate brain function and disease mechanisms in greater detail.

What roles do non-neuronal cells play in brain organoid development?

Glial cells (oligodendrocytes, microglia, and astrocytes) are examples of non-neuronal cells that are essential to the development of brain organoids. Astrocytes aid in the development of synapses, the blood-brain barrier (BBB), and neuronal function. Myelinating neurons require oligodendrocytes in order to transmit signals more quickly.

By regulating inflammation and preserving brain homeostasis, microglia support immunological responses. In organoid research, these non-neuronal cells enable neural growth, connection, and responsiveness to illness circumstances, resulting in a more realistic and functional brain model.

What are organoids of the human brain?

Human brain organoids are miniature, three-dimensional representations of the brain made from pluripotent stem cells, such as embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs). These organoids replicate essential features of the development of the human brain, including the establishment of fundamental brain structures and cellular differentiation into neurons and glial cells. Despite being smaller and more straightforward than the entire human brain, they offer essential information on neurological disorders, brain development, and brain function for both research and treatment.

Is the growth of human brain organoids ethical?

Concerns about consciousness and cognitive abilities are among the ethical issues raised by the development of human brain organoids. The growth of organoids may someday result in more complex structures that resemble the human brain, raising concerns about moral standing and rights even though they now lack subjective experiences.

Furthermore, significant thought must be given to the ethical considerations of ownership, consent, and privacy, as well as the possibility of abuse in research. To responsibly handle these issues, an "embedded ethics" approach incorporating interdisciplinary debates is necessary.

How do brain organoids mimic the human brain's developmental trajectory?

By reproducing phases of neural development, brain organoids replicate the developmental trajectory of the human brain. They begin as pluripotent stem cells and develop into neural progenitors, neurons, and glial cells in that order. Similar to the early phases of human brain formation, the organoids produce primitive layers, go through neurogenesis, and start to build synaptic connections.

However, directed procedures can encourage the development of particular brain areas, enabling organoids to mimic the structure of the human brain, including the forebrain, midbrain, and hindbrain.